Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Cat . Non | Espèces | Description du produit | Structure | Pureté | Caractéristique |
|---|---|---|---|---|---|
| CHEK-ATP124 | Human | HEK293/Human Claudin-1 Stable Cell Line | |||
| CL1-H52P6 | Human | Human Claudin-1 Full Length Protein (VLP) | |||
| CL1-H55D8 | Human | Human Claudin-1 Protein, Flag,His Tag (Detergent) |  |
|
Expression analysis of human Claudin-1 on HEK293/Human Claudin-1 Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Human Claudin-1 Stable Cell Line or negative control cell using
anti-human Claudin-1 antibody followed by staining with FITC anti-mouse IgG Fc Antibody.
Immobilized Human Claudin-1 Protein, Flag,His Tag (Cat. No. CL1-H55D8) at 5 μg/mL (100 μL/well) on a Nickel Coated plate can bind Monoclonal Anti-Human Claudin-1 antibody, Human IgG1 with a linear range of 0.001-0.625 μg/mL (QC tested).
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| ALE-C04 | ALE-C04; ALE.C04 | Phase 2 Clinical | Inserm | Head and Neck Neoplasms; Liver Neoplasms; Squamous Cell Carcinoma of Head and Neck; Cholangiocarcinoma | Details |
| ALE-P02 | ALE-P02; ALE.P02 | Phase 2 Clinical | Alentis Therapeutics AG | Solid tumours; Squamous Cell Carcinoma of Head and Neck; Esophageal Squamous Cell Carcinoma; Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms | Details |
| Lixudebart | ALE-F02; ALE-F-02 | Phase 2 Clinical | Alentis Therapeutics AG | Liver Cirrhosis; Renal fibrosis; Glomerulonephritis | Details |
This web search service is supported by Google Inc.
A-Z
